Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0R6AB
|
||||
Former ID |
DIB010170
|
||||
Drug Name |
Droxicam
|
||||
Synonyms |
Dobenam; Drogelon; Droxar; Ferpan; Ombolan; Precam; E-3128; E-318
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Inflammatory disease [ICD9: 140-229, 147, 173, 573.3, 710-719; ICD10:C11, C44, K75.9, M00-M25] | Withdrawn from market | [1] | ||
Company |
Esteve
|
||||
Structure |
![]() |
Download2D MOL |
|||
Formula |
C16H11N3O5S
|
||||
Canonical SMILES |
S1(=O)(=O)N(c2c(=O)n(c(=O)oc2c2c1cccc2)c1ncccc1)C
|
||||
CAS Number |
CAS 90101-16-9
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Cyclooxygenase | Target Info | Modulator | [2] | |
References | |||||
REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800003115) | ||||
REF 2 | Pharmacokinetic profile of droxicam. Eur J Rheumatol Inflamm. 1991;11(4):10-4. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.